Milestone Pharmaceuticals MIST Earnings Call Transcripts

NASDAQ MIST
$0.66 +0.00 (+0.00%)
At close: Nov 11, 2026 · 4:00 PM EST
2 earnings calls on file for Milestone Pharmaceuticals, from Q1 2026 to Q2 2026. Each transcript opens in a new tab.
Latest earnings call

Milestone Pharmaceuticals Q2 2026 Earnings Call

Aug 12, 2026 6,912 words · 30 min read
  • Joseph OlivetoPresident and Chief Executive Officer
  • Lorenz MullerChief Commercial Officer
  • Amit HasijaChief Financial Officer and EVP of Corporate Development
  • David BharuchaChief Medical Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Milestone Pharmaceuticals Earnings Call Transcripts

Calls2
LatestAug 12, 2026
SinceQ1 2026

Fiscal 2026

All 2 Milestone Pharmaceuticals transcripts Register to get access to Milestone Pharmaceuticals’s earnings call transcripts.